ARCHIVES

FDA Auditors Spend Two Weeks At Duke, Nevins Loses Position in Reorganization

This article is from The Cancer Letter archive.

Vol. 37 No. 04 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Doctor Files Defamation Suit Against Former Patient, But Legal Action Triggers Adverse Events

April 20, 2012

Evidence “Weak” Linking EMFs, cancer

June 25, 1999

Study Identifies Women Likely To Benefit From Therapy With Aromatase Inhibitors

November 24, 2006

Clinton Endorses Legislation Preventing Genetic Discrimination

May 23, 1997

Study Shows MammaPrint Test Can Predict 25-Year Risk Levels

February 28, 2014

Turmoil in Texas: DePinho Recommended AVEO Stock on CNBC Six Days After FDA Said New Trial Was Needed

May 10, 2013